Theraclone Sciences, Inc.

To hear OncoResponse Inc . CEO Clifford Stocks tell it, his company is “approaching that interesting time point where pharma likes to partner” as it readies lead candidate OR2805 for efficacy studies

AbCellera Secures $10m Series A Investment AbCellera Biologics Inc. raised $10m in its Series A financing round led by DCVC Bio, which adds 2 board seats. (Sep.) Founded in 2012 based on microfluidi

Coming from a fairly large firm – Cubist Pharmaceuticals Inc. – before its $8.4bn acquisition by Merck & Co. Inc. in 2014, Morphic Therapeutic Inc. President and CEO Praveen Tipirneni said he ex

During the final quarter of 2017, biopharma start-up fundraising showed a 17% decline from the previous quarter, a total of $2.62bn compared to $3.17bn in the third quarter. It was a continuing downwa